BIBA Medical Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News Neuro News CX Symposium ilegx BIBA MedTech Insights
login
  Password reminder

Subscribe Edit your account | View your account

Interventional News

The website for interventionalists

Contact us 

Follow us on twitter Find us on facebook
 




Featured Highlights
11 - 20 of 111   Items
Nordion launches updated TheraSphere website for liver cancer physicians, patients and carers

Nordion launches updated TheraSphere website for liver cancer physicians, patients and carers

Thursday, 07 Mar 2013
TheraSphere.com, the new TheraSphere website, provides resources and targeted information about radioembolization therapy and is available as an iPad app, according to a company release. read more

Study data suggests 95% cure rate for men with prostate cancer using high intensity focused ultrasound

Thursday, 07 Mar 2013
Prostate patients, according to data announced by the Diagnostic Center for Disease, Florida, USA, said that there could be a 95% cure rate when biopsy is used in conjunction with 3 telsa magnetic resonance imaging spectroscopy. read more

Surefire Medical infusion system can prevent embolics entering non-target vessels for the treatment of liver cancer

Thursday, 07 Mar 2013
According to Surefire Medical and a study published in CardioVascular and Interventional Radiology, the Surefire infusion system can prevent embolics, such as those used for treating liver cancer, entering distal non-target vessels. read more
TACE procedure in Japan and Korea was favourable for overall survival in hepatocellular carcinoma patients

TACE procedure in Japan and Korea was favourable for overall survival in hepatocellular carcinoma patients

Monday, 04 Mar 2013
According to results of a study published in the Journal of Vascular and Interventional Radiology, a transcatheter arterial chemoembolization (TACE) procedure using an emulsion of lipidol, an anthracycline agent and gelatin sponge particles, in Asia, was favourable for patient outcomes compared with Western TACE. read more
Coding Strategies offers new radiology and oncology HCPCS resource guides

Coding Strategies offers new radiology and oncology HCPCS resource guides

Monday, 04 Mar 2013
According to a company release, designed for quick and easy reference, Coding Strategies has launched two new HCPCS resource guides for radiology and oncology. read more
Lower rates of post-embolization syndrome and fatigue with smaller drug-eluting beads for hepatocellular carcinoma

Lower rates of post-embolization syndrome and fatigue with smaller drug-eluting beads for hepatocellular carcinoma

Friday, 22 Feb 2013
In a study published in the Journal of Vascular and Interventional Radiology, Siddharth A Padia and colleagues compared 100–300µm and 300–500µm drug-eluting beads for the treatment of hepatocellular carcinoma patients. read more
Benefits of computed tomography outweigh cancer risks in young adults

Benefits of computed tomography outweigh cancer risks in young adults

Thursday, 21 Feb 2013
A study, jointly led by Robert L Zondervan and Susanna Lee, has said that young adults who undergo computed tomography (CT) are more at risk from underlying medical conditions rather than radiation-induced cancer from CT. read more
Varian Medical Systems receives FDA 510(k) clearance for the Edge radiosurgery suite

Varian Medical Systems receives FDA 510(k) clearance for the Edge radiosurgery suite

Wednesday, 30 Jan 2013
Edge radiosurgery suite, a new dedicated system for performing advanced radiosurgery using real-time tumour tracking and motion management technologies, has been granted FDA approval. read more
Interventional treatment with radioactive beads could help colon cancer patients live longer

Interventional treatment with radioactive beads could help colon cancer patients live longer

Monday, 28 Jan 2013
In a presentation at ISET, data from a study using Y-90 radioactive beads for the treatment of liver-dominant metastases from colorectal cancer showed that patients may live longer than with chemotherapy alone. read more
Upgraded version of Accu2i pMTA microwave ablation device gets FDA clearance

Upgraded version of Accu2i pMTA microwave ablation device gets FDA clearance

Tuesday, 11 Dec 2012
Improvements of the new device include a refined optically clear moulded handle and improved connection cartridge. read more
Found: 111   Displaying: 11-20
Results: 1 2 3 4 5 Next Go to:
Related Section
Clinical Trials
Interventional Oncology News
Interventional Oncology Supplement
Key Opinion Leaders discuss the role of Biocompatible's DC Bead at CIRSE and ILCA
IR Views
Literature
Oncology Useful Links

Related Feeds

Latest News





Features





Profiles





BIBA Medical, 44 Burlington Road, Fulham, London, SW6 4NX.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions